Fact CheckerSign in

NCT06924463Recruiting

Identification of Specific Molecular Signatures in Pediatric, Adolescent, and Young Adult Rhabdomyosarcoma Through Spatial Proteome Analysis Using Mass Spectrometry

Identification de Signatures moléculaires spécifiques Dans le Rhabdomyosarcome de l'Enfant, de l'Adolescent et du Jeune Adulte, Par Analyse Spatiale du protéome Par spectrométrie de Masse

Source: ClinicalTrials.gov · Last updated 11 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This non-interventional study aims to develop spatial proteomics for analyzing small FFPE tumor samples in rhabdomyosarcoma. It will identify molecular signatures linked to tumor regions, subtypes, survival, and treatment resistance, using pre-existing samples and data.

Status (registry)
Recruiting
Study type
Observational
Enrollment
20 (estimated)
First submitted
4 Apr 2025
Start date
13 Mar 2025
Primary completion date
31 Dec 2025
Lead sponsor
Lille University
NCT number
NCT06924463

What you commit to

  • Study type: Observational
  • Planned participants: 20
  • From 13 Mar 2025 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Unavailability of biological sample in FFPE from biopsy and/or surgical specimen for diagnosis at Centre Oscar Lambret;

Other

  • Patient under guardianship or trusteeship.

Who the study is looking for

  • Age between 0 and 25 years at the time of initial diagnosis
  • Diagnosis of rhabdomyosarcoma confirmed histologically
  • Care at the Oscar Lambret Center between January 2005 and November 2024
  • No objection to the re-use of data and biological samples collected as part of care for research activities.

Age in the registry: 0 years to 25 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Oscar Lambret Center
Coordinator of this site? Confirm its status
LilleFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.